default author photo

Stephen TC Wong

Houston Methodist Cancer Center - Department of Systems Medicine and Bioengineering

Houston, TX

United States

  • Houston Methodist Cancer Center - Department of Systems Medicine and Bioengineering

SCHOLARLY PAPERS

3

DOWNLOADS

172

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Virtual Reality-Based Cognitive Stimulation - A Feasibility Clinical Trial

Number of pages: 29 Posted: 11 Sep 2023
Hina Faisal, Wesley Lim, Antara Dattagupta, Peter Lin, Rohan Gupta, Eugene Lai, Jiaqiong Xu, Stephen TC Wong and Faisal Masud
Houston Methodist Hospital - Department of Surgery, Texas A&M University, Texas A&M University, Texas A&M University, Texas A&M University, Houston Methodist Hospital - Stanley H. Appel Department of Neurology, Houston Methodist Research Institute - Houston Methodist Academic Institute, Houston Methodist Cancer Center - Department of Systems Medicine and Bioengineering and Houston Methodist Hospital - Department of Surgery
Downloads 106 (664,543)

Abstract:

Loading...

Cognitive therapy, virtual system, software design, video games, innovative therapy, delirium

2.

NOS2 and COX2 Blockade Limits TNBC Disease Progression and Alters CD8 T Cell Spatial Orientation and Density

Number of pages: 36 Posted: 30 Sep 2022
David A. Wink, Veena Somasundaram, Lisa A. Ridnour, Robert YS Cheng, Abigail J. Walke, Kedei Noemi, Dibyangana D. Bhattacharyya, Adelaide L. Wink, Elijah F. Edmondson, Donna Butcher, Warner C. Andrew, Tiffany Dorsey, David A. Scheiblin, Heinz William, Richard J. Bryant, Robert J. Kinders, Stan Lipkowitz, Stephen TC Wong, Milind Pore, Stephen M. Hewitt, Daniel w. McVicar, Stephen K. Anderson, Jenny C. Chang, Sharon A. Glynn, Stefan Ambs and Stephen Lockett
National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, Government of the United States of America - National Cancer Institute, National Cancer Institute - Center for Cancer Research, National Laboratory for Cancer Research, Government of the United States of America - Frederick National Laboratory for Cancer Research, Molecular Histopathology Laboratories, Leidos Biomedical Research Inc., Molecular Histopathology Laboratories, Leidos Biomedical Research Inc., Government of the United States of America - Laboratory of Human Carcinogenesis, National Laboratory for Cancer Research, Government of the United States of America - Frederick National Laboratory for Cancer Research, University of Oxford - Nuffield Department of Surgical Sciences, Office of the Director, Division of Cancer Treatment and Diagnosis, Government of the United States of America - National Cancer Institute, Houston Methodist Cancer Center - Department of Systems Medicine and Bioengineering, Government of the United States of America - Frederick National Laboratory for Cancer Research, Government of the United States of America - National Cancer Institute, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, Houston Methodist Hospital - Houston Methodist Cancer Center, University of Galway, Government of the United States of America - Laboratory of Human Carcinogenesis and National Laboratory for Cancer Research
Downloads 42 (1,170,409)

Abstract:

Loading...

Triple Negative Breast Cancer, NOS2, COX2, Immune Response

3.

NOS2 and COX2 Blockade Limits TNBC Disease Progression and Alters CD8+ T Cell Spatial Orientation and Density

Number of pages: 23 Posted: 16 Aug 2022
David A. Wink, Veena Somasundaram, Lisa A. Ridnour, Robert YS Cheng, Abigail J. Walke, Kedei Noemi, Dibyangana D. Bhattacharyya, Adelaide L. Wink, Elijah F. Edmondson, Donna Butcher, Warner C. Andrew, Tiffany Dorsey, David A. Scheiblin, Heinz William, Richard J. Bryant, Robert J. Kinders, Stan Lipkowitz, Stephen TC Wong, Milind Pore, Stephen M. Hewitt, Daniel w. McVicar, Stephen K. Anderson, Jenny C. Chang, Sharon A. Glynn, Stefan Ambs and Stephen Lockett
National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, Government of the United States of America - National Cancer Institute, National Cancer Institute - Center for Cancer Research, National Laboratory for Cancer Research, Government of the United States of America - Frederick National Laboratory for Cancer Research, Molecular Histopathology Laboratories, Leidos Biomedical Research Inc., Molecular Histopathology Laboratories, Leidos Biomedical Research Inc., Government of the United States of America - Laboratory of Human Carcinogenesis, National Laboratory for Cancer Research, Government of the United States of America - Frederick National Laboratory for Cancer Research, University of Oxford - Nuffield Department of Surgical Sciences, Office of the Director, Division of Cancer Treatment and Diagnosis, Government of the United States of America - National Cancer Institute, Houston Methodist Cancer Center - Department of Systems Medicine and Bioengineering, Government of the United States of America - Frederick National Laboratory for Cancer Research, Government of the United States of America - National Cancer Institute, National Cancer Institute - Center for Cancer Research, National Cancer Institute - Center for Cancer Research, Houston Methodist Hospital - Houston Methodist Cancer Center, University of Galway, Government of the United States of America - Laboratory of Human Carcinogenesis and National Laboratory for Cancer Research
Downloads 24 (1,411,822)

Abstract:

Loading...

NOS2, COX2, TNBC, CD8+ T cells